179 related articles for article (PubMed ID: 29054497)
1. Association between male pattern baldness and prostate disease: A meta-analysis.
Jin T; Wu T; Luo Z; Duan X; Deng S; Tang Y
Urol Oncol; 2018 Feb; 36(2):80.e7-80.e15. PubMed ID: 29054497
[TBL] [Abstract][Full Text] [Related]
2. Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysis.
He H; Xie B; Xie L
Medicine (Baltimore); 2018 Jul; 97(28):e11379. PubMed ID: 29995779
[TBL] [Abstract][Full Text] [Related]
3. Early onset baldness and prostate cancer risk.
Denmark-Wahnefried W; Schildkraut JM; Thompson D; Lesko SM; McIntyre L; Schwingl P; Paulson DF; Robertson CN; Anderson EE; Walther PJ
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):325-8. PubMed ID: 10750672
[TBL] [Abstract][Full Text] [Related]
4. Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis.
Liang W; Song L; Peng Z; Zou Y; Dai S
BMC Cancer; 2018 Mar; 18(1):279. PubMed ID: 29529997
[TBL] [Abstract][Full Text] [Related]
5. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels.
Faydaci G; Bilal E; Necmettin P; Fatih T; Asuman O; Uğur K
Aging Male; 2008 Dec; 11(4):189-92. PubMed ID: 19172550
[TBL] [Abstract][Full Text] [Related]
6. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
[TBL] [Abstract][Full Text] [Related]
7. Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
Salmon C; Mesidor M; Rousseau MC; Richard H; Weiss D; Spence AR; Parent ME
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):143-150. PubMed ID: 37851110
[TBL] [Abstract][Full Text] [Related]
8. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.
Kucerova R; Bienova M; Kral M; Bouchal J; Trtkova KS; Burdova A; Student V; Kolar Z
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):91-6. PubMed ID: 24665929
[TBL] [Abstract][Full Text] [Related]
9. Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis.
Amoretti A; Laydner H; Bergfeld W
J Am Acad Dermatol; 2013 Jun; 68(6):937-43. PubMed ID: 23395589
[TBL] [Abstract][Full Text] [Related]
10. Male pattern baldness and risk of colorectal neoplasia.
Keum N; Cao Y; Lee DH; Park SM; Rosner B; Fuchs CS; Wu K; Giovannucci EL
Br J Cancer; 2016 Jan; 114(1):110-7. PubMed ID: 26757425
[TBL] [Abstract][Full Text] [Related]
11. Association between male pattern baldness and testicular germ cell tumor: a meta-analysis.
Zhou J; Xia S; Li T; Liu R
BMC Cancer; 2019 Jan; 19(1):53. PubMed ID: 30634927
[TBL] [Abstract][Full Text] [Related]
12. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
[TBL] [Abstract][Full Text] [Related]
13. Association of benign prostatic hyperplasia with male pattern baldness.
Oh BR; Kim SJ; Moon JD; Kim HN; Kwon DD; Won YH; Ryu SB; Park YI
Urology; 1998 May; 51(5):744-8. PubMed ID: 9610587
[TBL] [Abstract][Full Text] [Related]
14. Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study.
Khan S; Caldwell J; Wilson KM; Gonzalez-Feliciano AG; Peisch S; Pernar CH; Graff RE; Giovannucci EL; Mucci LA; Gerke TA; Markt SC
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1229-1236. PubMed ID: 32277004
[TBL] [Abstract][Full Text] [Related]
15. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.
Papa NP; MacInnis RJ; English DR; Bolton D; Davis ID; Lawrentschuk N; Millar JL; Severi G; Hopper JL; Giles GG
Cancer Causes Control; 2018 Jan; 29(1):93-102. PubMed ID: 29139043
[TBL] [Abstract][Full Text] [Related]
16. Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.
Dai X; Fang X; Ma Y; Xianyu J
Medicine (Baltimore); 2016 May; 95(18):e3493. PubMed ID: 27149447
[TBL] [Abstract][Full Text] [Related]
17. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey.
Hawk E; Breslow RA; Graubard BI
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):523-7. PubMed ID: 10815699
[TBL] [Abstract][Full Text] [Related]
18. Male-pattern baldness and incident coronary heart disease and risk factors in the Heinz Nixdorf Recall Study.
Pechlivanis S; Heilmann-Heimbach S; Erbel R; Mahabadi AA; Hochfeld LM; Jöckel KH; Nöthen MM; Moebus S
PLoS One; 2019; 14(11):e0225521. PubMed ID: 31743359
[TBL] [Abstract][Full Text] [Related]
19. Patients with a large prostate show a higher prevalence of androgenetic alopecia.
Chen W; Yang CC; Chen GY; Wu MC; Sheu HM; Tzai TS
Arch Dermatol Res; 2004 Nov; 296(6):245-9. PubMed ID: 15517324
[TBL] [Abstract][Full Text] [Related]
20. Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.
Zhou CK; Littman AJ; Levine PH; Hoffman HJ; Cleary SD; White E; Cook MB
Prostate; 2015 Mar; 75(4):415-23. PubMed ID: 25492530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
